Teva Pharmaceuticals USA Recall: Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL
Teva Pharmaceuticals USA Recall: Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Teva Pharmaceuticals USA; Product: Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vial NDC 0703-4502-01), packaged in 25 x 2 mL
| Recalling firm | Teva Pharmaceuticals USA |
|---|---|
| Product | Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vial NDC 0703-4502-01), packaged in 25 x 2 mL Single-Use Vials per tray (NDC 0703-4502-04), Rx only, Teva Parenteral Medicines, Inc., Irvine, CA 92618. |
| Reason for recall | Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Product was distributed nationwide in the USA and Puerto Rico. |
| Recall initiated | 20210210 |
| Recall number | D-0277-2021 |
| Category | drug |
| State | NJ |
| Country | United States |
$29/mo
Try RecallGuard →